ACADIA Pharmaceuticals (NASDAQ:ACAD) reported Q4 2017 earnings this Afternoon, coming in at $1.54 per share, beating Wall Street’s estimates of $1.40 per Share. Revenue for the quarter came in at $2.96 billion beating analyst estimates of $2.82 billion

Recent Trading for ACADIA Pharmaceuticals (NASDAQ:ACAD)
Shares of ACADIA Pharmaceuticals closed the previous trading session at 27.42 down -3.74 12.02% with 32.130001068115234 shares trading hands.